Citadel Advisors
GMDA

Citadel Advisors’s Gamida Cell Ltd. Ordinary Shares GMDA Stock Holding History

Citadel Advisors’s Portfolio GMDA Stock Details GMDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-33,700
Closed -$1.22K – 15854
2024
Q1 		$1.22K Sell
33,700
-5,800
-15% -$1.98K ﹤0.01% 14163
2023
Q4 		$16.3K Sell
39,500
-49,100
-55% -$27.7K ﹤0.01% 12799
2023
Q3 		$91.3K Sell
88,600
-90,700
-51% -$116K ﹤0.01% 11008
2023
Q2 		$346K Buy
179,300
+128,700
+254% +$221K ﹤0.01% 8728
2023
Q1 		$41K Buy
50,600
+8,000
+19% +$11.7K ﹤0.01% 12408
2022
Q4 		$55K Sell
42,600
-5,200
-11% -$8.22K ﹤0.01% 12012
2022
Q3 		$76K Buy
47,800
+30,300
+173% +$69.1K ﹤0.01% 11317
2022
Q2 		$31K Sell
17,500
-39,000
-69% -$99.1K ﹤0.01% 12212
2022
Q1 		$234K Buy
56,500
+31,500
+126% +$106K ﹤0.01% 11158
2021
Q4 		$64K Buy
+25,000
New +$82.3K ﹤0.01% 13100
2021
Q3 		– Sell
-21,400
Closed -$137K – 14893
2021
Q2 		$137K Sell
21,400
-15,800
-42% -$109K ﹤0.01% 12598
2021
Q1 		$301K Buy
+37,200
New +$342K ﹤0.01% 10855

Other funds holding GMDA

PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Citadel Advisors's GMDA Position: Q2 2024 in Review

Citadel Advisors sold out of Gamida Cell Ltd. Ordinary Shares (GMDA) in Q2 2024, closing a stake of 18,890 shares — an estimated $682 sold.

Citadel Advisors first reported a position in GMDA in Q3 2020 and held it in 10 quarters. The position peaked at $381K in Q1 2021. 2 funds tracked by Wall St. Rank hold GMDA as of Q2 2024.

  • Citadel Advisors reported no remaining Gamida Cell Ltd. Ordinary Shares position as of Q2 2024 after selling out during the quarter.
  • Citadel Advisors sold 18,890 Gamida Cell Ltd. Ordinary Shares shares in Q2 2024, an estimated $682.
  • Citadel Advisors first reported a position in Gamida Cell Ltd. Ordinary Shares in Q3 2020 and held it in 10 quarters.
  • Citadel Advisors's Gamida Cell Ltd. Ordinary Shares position peaked at $381K in Q1 2021.
  • 2 funds tracked by Wall St. Rank held Gamida Cell Ltd. Ordinary Shares as of Q2 2024.

Based on Citadel Advisors's 13F filing for Q2 2024, filed 14 Aug 2024.